pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 1
    vobramitamab tavatecan
    vobramitamab tavatecan[INN]
    Bladder Cancer$MGNX MACROGENICS INC
  • Phase 2
    vodobatinib
    vodobatinib
    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Sun Pharma Advanced Research Company Ltd
  • Phase 2
    vopimetostat
    vopimetostat [INN]
    Bladder Cancer$TNGX Tango Therapeutics, Inc.
← prev
page 61 of 62
next →
Pain89
Neurology1
Marketed
vorasidenib citrate
Voranigo (vorasidenib citrate)
Low-Grade Glioma
Les Laboratoires Servier SAS
  • Marketed
    vorinostat
    Zolinza (vorinostat)
    Cutaneous T-Cell Lymphoma$MRK Merck & Co., Inc.
  • Phase 2
    vosilasarm
    vosilasarm
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Ellipses Pharma Ltd
  • Phase 2
    vusolimogene oderparepvec
    vusolimogene oderparepvec
    Basal Cell Carcinoma (Basal Cell Epithelioma)$REPL Replimune Group, Inc.
  • Phase 3
    xaluritamig
    xaluritamig [INN]
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$AMGN AMGEN INC
  • Phase 1
    xirestomig
    xirestomig [INN]
    Non-Hodgkin Lymphoma Antengene Corp Ltd
  • Phase 2
    zabilugene almadenorepvec
    zabilugene almadenorepvec
    Pancreatic Ductal Adenocarcinoma$TOVX Theriva Biologics, Inc.
  • Phase 2
    zalifrelimab
    zalifrelimab
    Cervical Cancer$AGEN AGENUS INC
  • Phase 1
    zaloblideg
    zaloblideg [INN]
    Diffuse Large B-Cell Lymphoma$ARVN ARVINAS, INC.
  • pre_registration
    zanidatamab
    Ziihera (zanidatamab-hrii)
    Adenocarcinoma Of The Gastroesophageal Junction$JAZZ Jazz Pharmaceuticals plc
  • pre_registration
    zanzalintinib fumarate
    zanzalintinib fumarate
    Metastatic Colorectal Cancer$EXEL EXELIXIS, INC.
  • Phase 1
    zavondemstat
    zavondemstat [INN]
    Gastrointestinal Tumor Tachyon Therapeutics Inc
  • Phase 1
    zelebrudomide
    zelebrudomide
    Diffuse Large B-Cell Lymphoma$NRIX Nurix Therapeutics, Inc.
  • Phase 2
    zelenirstat
    zelenirstat [INN]
    Refractory Acute Myeloid Leukemia Pacylex Pharmaceuticals Inc
  • pre_registration
    zenocutuzumab
    Bizengri (zenocutuzumab-zbco)
    Bile Duct Cancer (Cholangiocarcinoma) Merus NV
  • pre_registration
    zidesamtinib
    zidesamtinib
    Non-Small Cell Lung Cancer$NUVL Nuvalent, Inc.
  • Marketed
    ziftomenib
    Komzifti (ziftomenib)
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)$KURA Kura Oncology, Inc.
  • Phase 2
    zilovertamab vedotin
    zilovertamab vedotin [INN]
    Mantle Cell Lymphoma$MRK Merck & Co., Inc.
  • Phase 2
    zilurgisertib fumarate
    zilurgisertib fumarate
    Fibrodysplasia Ossificans Progressiva (Myositis Ossifican…$INCY INCYTE CORP
  • Phase 2
    zimberelimab
    zimberelimab
    Adenocarcinoma Of The Gastroesophageal Junction$RCUS Arcus Biosciences, Inc.
  • pre_registration
    zipalertinib
    zipalertinib
    Non-Small Cell Lung Cancer Taiho Pharmaceutical Co Ltd
  • Marketed
    ziv-aflibercept
    Zaltrap (ziv-aflibercept [INN])
    Metastatic Colorectal Cancer Sanofi-Aventis US LLC
  • Phase 3
    zocilurtatug pelitecan
    zocilurtatug pelitecan
    Small-Cell Lung Cancer$ZLAB Zai Lab Ltd
  • Phase 2
    zolbetuximab
    Vyloy (zolbetuximab-clzb)
    Metastatic Adenocarcinoma of The Pancreas Astellas Pharma Inc
  • Phase 2
    zolucatetide
    zolucatetide [INN]
    Craniopharyngioma Parabilis Medicines
  • Phase 2
    zotiraciclib citrate
    zotiraciclib citrate
    Glioblastoma Multiforme (GBM) Beijing zhikangbo Medical Oncology Research Co Ltd
  • Phase 3
    zovegalisib
    zovegalisib [INN]
    Human Epidermal Growth Factor Receptor 2 Negative Breast…$RLAY Relay Therapeutics, Inc.